FDA Drug Application (021924) for TIROSINT by INSTITUT BIOCHIMIQUE

Back to FDA Applications sponsored by INSTITUT BIOCHIMIQUE

Application Number021924
Product Number002
FormCAPSULE;ORAL
Dosage0.025MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTIROSINT
Active IngredientLEVOTHYROXINE SODIUM

Active IngredientCount
List of drugs with Active Ingredient LEVOTHYROXINE SODIUM9


Back to FDA Applications sponsored by INSTITUT BIOCHIMIQUE